Molecular Imaging of Malignant Tumor Metabolism. Whole-Body Image Fusion of DWI/CT vs. PET/CT

Academic Radiology

Volumn 18, Issue 8, 2011, Pages 940-946

  Reiner, Caecilia S ^a   Fischer, Michael A ^a   Hany, Thomas ^a   Stolzmann, Paul ^a,c   Nanz, Daniel ^a   Donati, Olivio F ^a   Weishaupt, Dominik ^b   von Schulthess, Gustav K ^a   Scheffel, Hans ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diffusion weighted imaging; Image fusion; Molecular imaging; Positron emission tomography; Tumor metabolism; Whole body imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; COLORECTAL CANCER; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; ESOPHAGUS CANCER; FALSE POSITIVE RESULT; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; IMAGE QUALITY; LYMPH NODE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; METASTASIS; MOLECULAR IMAGING; PANCREAS CANCER; PHARYNX CANCER; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH CANCER; WHOLE BODY DIFFUSION WEIGHTED IMAGING; WHOLE BODY IMAGING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 79959738748     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.03.010     Document Type: Article

References (35)

1. Beyer T., Townsend D.W., Blodgett T.M. Dual-modality PET/CT tomography for clinical oncology. Q J Nucl Med 2002, 46:24-34.
2. Hany T.F., Steinert H.C., Goerres G.W., et al. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002, 225:575-581.
3. Pelosi E., Messa C., Sironi S., et al. Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging 2004, 31:932-939.
4. Low R.N., Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 2007, 25:848-858.
5. Komori T., Narabayashi I., Matsumura K., et al. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med 2007, 21:209-215.
6. Stecco A., Romano G., Negru M., et al. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol Med 2009, 114:1-17.
7. Sakurada A., Takahara T., Kwee T.C., et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 2009, 19:1461-1469.
8. Nakanishi K., Kobayashi M., Nakaguchi K., et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci 2007, 6:147-155.
9. Glazer G.M., Gross B.H., Quint L.E., et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 1985, 144:261-265.
10. Dorfman R.E., Alpern M.B., Gross B.H., et al. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991, 180:319-322.
11. Whittaker C.S., Coady A., Culver L., et al. Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review. Radiographics 2009, 29:759-774. discussion 774-758.
12. Landis J.R., Koch G.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977, 33:363-374.
13. Wolz G., Nomayr A., Hothorn T., et al. Anatomical accuracy of interactive and automated rigid registration between X-ray CT and FDG-PET. Nuklearmedizin 2007, 46:43-48.
14. Murtz P., Krautmacher C., Traber F., et al. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 2007, 17:3031-3037.
15. Ruers T.J., Langenhoff B.S., Neeleman N., et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002, 20:388-395.
16. Antoch G., Vogt F.M., Freudenberg L.S., et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 2003, 290:3199-3206.
17. Laurent V., Trausch G., Bruot O., et al. Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT. Eur J Radiol 2010, 75:376-383.
18. Schmidt G.P., Baur-Melnyk A., Herzog P., et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 2005, 40:743-753.
19. Pfannenberg C., Aschoff P., Schanz S., et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 2007, 43:557-564.
20. Uto T., Takehara Y., Nakamura Y., et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009, 252:247-254.
21. Mori T., Nomori H., Ikeda K., et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol 2008, 3:358-364.
22. Fischer M.A., Nanz D., Hany T., et al. Diagnostic accuracy of whole-bodyMRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT. Eur Radiol 2011, 21:246-255.
23. Manfredi R., Pirronti T., Bonomo L., et al. Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma. MAGMA 1996, 4:257-262.
24. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000, 343:254-261.
25. Reinhardt M.J., Ehritt-Braun C., Vogelgesang D., et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001, 218:776-782.
26. Rosenbaum S.J., Lind T., Antoch G., et al. False-positive FDG PET uptake-the role of PET/CT. Eur Radiol 2006, 16:1054-1065.
27. Vilanova J.C., Barcelo J. Diffusion-weighted whole-body MR screening. Eur J Radiol 2008, 67:440-447.
28. Lichy M.P., Aschoff P., Plathow C., et al. Tumor detection by diffusion-weighted MRI and ADC-mapping-initial clinical experiences in comparison to PET-CT. Invest Radiol 2007, 42:605-613.
29. Takenaka D., Ohno Y., Matsumoto K., et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 2009, 30:298-308.
30. Rohren E.M., Provenzale J.M., Barboriak D.P., et al. Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. Radiology 2003, 226:181-187.
31. Kitajima K., Nakamoto Y., Okizuka H., et al. Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors. Ann Nucl Med 2008, 22:595-602.
32. Okamoto K., Ito J., Ishikawa K., et al. Diffusion-weighted echo-planar MR imaging in differential diagnosis of brain tumors and tumor-like conditions. Eur Radiol 2000, 10:1342-1350.
33. Duygulu G., Ovali G.Y., Calli C., et al. Intracerebral metastasis showing restricted diffusion: correlation with histopathologic findings. Eur J Radiol 2010, 74:117-120.
34. Squillaci E., Manenti G., Di Stefano F., et al. Diffusion-weighted MR imaging in the evaluation of renal tumours. J Exp Clin Cancer Res 2004, 23:39-45.
35. Lyng H., Haraldseth O., Rofstad E.K. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000, 43:828-836.